An experimental cancer vaccine has shown promise in keeping certain cancers from coming back. In a phase 1 clinical trial led in part by the UCLA Health Jonsson Comprehensive Cancer Center, ...

Aspirin can cut by more than half the risk that colon cancer will come back following initial treatment, a new clinical trial has found. Daily aspirin reduced by 55% the risk of cancer recurrence in ...

A common over-the-counter medication could significantly reduce the risk of colorectal cancer coming back. In a Swedish study, a low dose of aspirin was shown to slash recurrence in half for patients ...